Pinmirol Plus 5 mg/5 mg/12,5 mg tvrde kapsule
| Name | Pinmirol Plus 5 mg/5 mg/12,5 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-258726339 |
| Active Substance | ramipril amlodipinbesilat hidroklorotiazid |
| Composition | jedna kapsula sadrži 5 mg ramiprila, 5 mg amlodipina (u obliku amlodipinbesilata), 12,5 mg hidroklorotiazida |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska |
| Marketing Authorisation Holder | Genericon Pharma Gesellschaft m.b.H., Hafnerstraße 211, Graz, Austrija |
| Marketing Authorisation Date | 29.11.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/21 |
| Registration Number | 381-12-01/70-23-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BX03 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
